BMI Korea Co., Ltd

République de Corée

 
Quantité totale PI 11
Rang # Quantité totale PI 140 883
Note d'activité PI 1,4/5.0    5
Rang # Activité PI 197 349
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

3 0
0 0
7 0
1
 
Dernier brevet 2025 - Composition for subcutaneous adm...
Premier brevet 2012 - Composition for inhibiting after...
Dernière marque 2019 - HILEUKIN-2
Première marque 2019 - HILEUKIN-2

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Composition for subcutaneous administration comprising hyaluronidase polypeptide and drug. The pr...
2022 Invention Hyaluronidase polypeptide and use thereof. The present invention relates to a hyaluronidase polyp...
2021 Invention Composition, for osteoarthritis treatment, comprising hydrophilized sulfasalazine and hyaluronic ...
2019 P/S Immunostimulants; Pharmaceutical products for the treatment of viral diseases; Pharmaceutical pre...
2017 Invention Hemostatic composition comprising cross-linked hyaluronic acid derivative matrix. The present inv...
Invention Hemostasis composition including cross-linking hyaluronic acid derivative matrix. The present inv...
Invention Stabilizer for hyaluronidase and liquid formulation comprising hyaluronidase. This invention rel...
2016 Invention Composition for injection of hyaluronic acid, containing hyaluronic acid derivative and dna fract...
2013 Invention Stabilizer for hyaluronidase and liquid formulation comprising hyaluronidase. 2. The liquid formu...
Invention Stabilizer for hyaluronidase and liquid formulation comprising hyaluronidase. This invention rela...
2012 Invention Composition for inhibiting after-cataract and method of preparing the same. The present invention...
Invention Composition for inhibiting after-cataract and method for preparing same. The present invention re...